Novel Therapies calls for papers / meetings & conferences

Call for Abstracts: Accelerating Translational Neurotechnology: Fourth Annual Aspen Brain Forum

September 18 - 20, 2013 Aspen Meadows Resort

Presented by The Aspen Brain Forum Foundation, Science Translational Medicine, and the New York Academy of Sciences

Neurotechnology encompasses electrical, chemical, and medical devices and products that can interact with or intervene in the activity of the central nervous system. These technologies include neuroprosthetics, neuroengineering, neuroimaging, optogenetics, neuromodulation, and neural stem cell therapies. Translating neurotechnologies from the laboratory into clinical and commercial products has been an arduous process. Yet many of these new tools show great potential to revolutionize the treatment of neurological diseases and disorders including depression, pain, headache, epilepsy, neuromuscular disease, Alzheimer's disease, Parkinson's disease, and traumatic brain injury.

Through a series of plenary sessions, panel discussions, and interactive breakout groups, this 2.5-day international conference shall explore innovative scientific, clinical, and organizational models for advancing the translation of neuroscience research into technology that can dramatically improve diagnosis and treatment of neurological and psychiatric disease. Participants will also examine the ethical and regulatory challenges in translating neuroscience research, and the potential economic impact of their clinical application.

This conference includes a breakout session. During registration, you will be asked to choose a work group based on your area/disease of interest. Please pick your first and second choices for this session. You may also write in an alternate topic. We will create additional groups if there is sufficient interest. Registrants will receive an email with work group details several weeks prior to the conference.

Choices include: Parkinson's Disease, Major Depression and other Mood Disorders, Chronic Pain, Alzheimer's Disease, or Traumatic Brain Injury.

Call for Abstracts

The deadline for abstract submission is Monday, July 1, 2013. For complete abstract instructions, please send an e-mail to neurotech@nyas.org with "Abstract Information" in the subject line. There is no need to type a message; instructions will be forwarded automatically. Select abstracts will be chosen to participate as short oral presentations for Session 6: Cutting-Edge Innovations in Neurotechnology. Please call 212.298.8632 with any questions.

Call for Investigational and Emerging Technologies Edited Live Case Presentations: TCT 25

October 27-November 1, 2013 San Francisco, California

Submission Deadline: July 26, 2013

A presentation opportunity at TCT 2013, you can submit your own edited taped case demonstrating a novel therapeutic or imaging technology in coronary, peripheral, or structural heart disease intervention that provides a unique solution for an unmet clinical need. The technology can be either investigational or in clinical use outside of the United States but not yet commercially available in the United States.

Case submitters will have the opportunity to present the edited taped case during TCT Week to a world-renowned panel of key opinion leaders, and those with accepted submissions will become TCT faculty and have their registration fees waived. Excellent examples include new percutaneous valves, heart failure support devices, novel peripheral atherectomy system, cerebral thrombus extraction device, large hole vascular closure, etc.

Description of an Edited Live Case

An edited live case is a case demonstration that typically consists of capturing the following elements of an interventional procedure performed in a cath lab in real time:

• Narrated patient history slides and an introduction of the case

• A wide camera shot of the primary operator from across the table narrating the demonstration

• A close up camera shot of devices and techniques from the foot of the table

• Live imaging captured from fluoroscopy, echo, IVUS, etc

These sources are then edited together with the operator's audio narration to show a point of interest at each phase of the case. Often picture-in-picture (PIP) technology is used to allow for multiple images to appear on screen concurrently. Periods of inactivity are removed to reduce the overall playtime of the case.

Please view a sample of an edited case: www.crf.org/jchamlee/i2_cases.html

Submission Guidelines

Step 1: Case Summary

• A written summary no more than 500 words describing your case. This is submitted online

• The deadline to submit your summary is July 26, 2013

After receiving notification of your accepted summary, you will be asked to complete step 2 (below).

Step 2: Edited Live Case

• Insert two (2) to three (3) introductory slides describing the technology at the beginning of the edited taped case

• The edited case must be submitted by express mail on a playable DVD, NTSC 4:3 format and can be no longer than 15 minutes

• The case should be edited so there are clear and concise teaching points. There should also be places in the presentation where the case can be paused to allow for panel discussion.

• The presentation is strictly for educational purpose and is not promotional although the company manufacturing the device may be acknowledged once at the beginning of the presentation

• No company logos are allowed

• All patient identifying information must be removed throughout the presentation in accordance with HIPAA guidelines

Final cases will be reviewed for acceptance. Accepted cases will be reviewed and additional edits may be suggested as necessary.

If you have questions about the suitability of a device, please contact Margaret Zetts at mzetts@crf.org.

Call for Abstracts: Options for the Control of Influenza VIII 

September 5-10, 2013 Cape Town, South Africa

Held every 3 years, Options for the Control of Influenza is the largest international scientific conference exclusively devoted to influenza.  Options VIII will showcase recent advances in the basic science and control and prevention of influenza.  Whatever your domain of expertise – virology, veterinary medicine, human medicine, public health policy, industry or journalism – Options for the Control of Influenza VIII is the premier conference bringing together experts dedicated to all aspects of influenza.  Presentation formats will include keynote addresses, invited lectures, scientific workshops, abstract presentations, satellite meetings and poster sessions.

The Conference Chairs welcome your latest scientific research on influenza for Oral or Poster presentation during the Options for the Control of Influenza VIII conference.

Categories for Abstract Submission:

•Animal Human Interface and Zoonotic Influenza

•Animal Influenza

•Animal Models for Influenza

•Antiviral Drugs and Resistance

•Clinical Management

•Diagnostics

•Disease Burden and Health Economics

•Epidemiology including Seroepidemiology

•Innate and Adaptive Immunity

•Mathematical Models Informing Public Health Decisions

•Novel Therapeutic Strategies

•Pandemic Mitigation: What Worked and What Did Not

•Pathogenesis and Systems Biology

•Risk Communication in Influenza

•Science Policy Interface

•Transmission and Infection Control

•Vaccines

•Viral Genomics and Evolution

•Viral Surveillance and the Global Influenza Surveillance Network

•Virology and Viral Receptors

To submit an abstract, please visit the Options VIII Abstract Submission System for submission instructions and parameters.

Submissions will be accepted until 3 June 2013.

For questions regarding abstract submission, please contact us at abstracts@controlinfluenza.com.

Call for Abstracts: 62nd Annual Montagna Symposium on the Biology of Skin, Light and Skin: How Light Sustains, Damages, Treats, Images and Modifies Skin Biology

October 10-14, 2013 Skamania Lodge, Washington

Deadline: July 1, 2013

A limited number of posters selected from submitted abstracts will be accepted for presentation at the meeting, and submissions for short oral presentations will be selected from abstracts to create the final program of meeting speakers.

The 62nd Annual Montagna Symposium on the Biology of Skin, Light and Skin: How Light Sustains, Damages, Treats, Images and Modifies Skin Biology, will examine how light affects skin biology as well as skin biology's impact on the newest uses of light.

Topics to be discussed include:

DNA effects, environmental change, photobiology and immunology

Photodynamic therapy, laser treatment, biostimulation, pulsed laser thermal effects, photoacoustic effects, low-level visible and near-IR effects

Live microscopy, diagnostics and technical tools, application areas, imaging of skin cancer and deep skin optical imaging

For more information

Dept. of Dermatology
Mail Code: L468R
Oregon Health & Sci Univ
3181 SW S Jackson Pk Rd
Portland, OR 97239

Office: (503) 418-4273
Fax: (503) 418-4266
info(at)
montagnasymposium.org

Call for Abstracts: 3rd World Congress of the International Society for Fertility Preservation (ISFP)

November 7-9, 2013 Valencia, Spain 

Abstract submission deadline: August 7, 2013

We invite you to take part in the 3rd World Congress on the International Society for Fertility Preservation (ISFP) which will take place in Valencia, Spain on November 7-9, 2013.

Fertility preservation is a substantial quality of life issue for young cancer survivors. As a consequence, the demand for fertility preservation has dramatically increased. The aim of the Congress is to update current scientific and clinical development of fertility preservation strategies. The Congress will not only propagate the current knowledge but also provide an opportunity for networking.

This congress is designed for reproductive endocrinologists, hematology-oncologists, gynecologic oncologists, psychologists, basic scientists, clinical researchers, oncology nurses, REI nurses, oncology social workers and others interested in fertility preservation.

During this congress, participants will be able to:

- Educate medical professionals to facilitate FP referrals
- Define the ethical and legal issues related to FP
- Explain the impact of cancer treatment on fertility and reproduction.
- Evaluate the current status of gamete Cryopreservation.
- Assess the strategies and values of emerging technology in ovarian transplantation.
- Recognize basic physiology and effects of Cryopreservation.
- Analyze physiology and current techniques of folliculogenesis and IVM.
- Identify new fertility preservation technologies